182 related articles for article (PubMed ID: 19710174)
1. Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.
Jin N; Cho SN; Raso MG; Wistuba I; Smith Y; Yang Y; Kurie JM; Yen R; Evans CM; Ludwig T; Jeong JW; DeMayo FJ
Development; 2009 Oct; 136(19):3347-56. PubMed ID: 19710174
[TBL] [Abstract][Full Text] [Related]
2. Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis.
Liu J; Cho SN; Wu SP; Jin N; Moghaddam SJ; Gilbert JL; Wistuba I; DeMayo FJ
Lung Cancer; 2017 Oct; 112():47-56. PubMed ID: 29191600
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma.
Reschke M; Ferby I; Stepniak E; Seitzer N; Horst D; Wagner EF; Ullrich A
Hepatology; 2010 Apr; 51(4):1383-90. PubMed ID: 20044804
[TBL] [Abstract][Full Text] [Related]
4. Evidence that MIG-6 is a tumor-suppressor gene.
Zhang YW; Staal B; Su Y; Swiatek P; Zhao P; Cao B; Resau J; Sigler R; Bronson R; Vande Woude GF
Oncogene; 2007 Jan; 26(2):269-76. PubMed ID: 16819504
[TBL] [Abstract][Full Text] [Related]
5. MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT.
Yoo JY; Kang HB; Broaddus RR; Risinger JI; Choi KC; Kim TH
BMC Cancer; 2018 May; 18(1):605. PubMed ID: 29843645
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling.
Li Z; Dong Q; Wang Y; Qu L; Qiu X; Wang E
Mol Carcinog; 2012 Jul; 51(7):522-34. PubMed ID: 21739478
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
Kang DH; Jung SS; Yeo MK; Lee DH; Yoo G; Cho SY; Oh IJ; Kim JO; Park HS; Chung C; Lee JE
BMC Cancer; 2020 Jun; 20(1):571. PubMed ID: 32552717
[TBL] [Abstract][Full Text] [Related]
8. Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines.
Li ZX; Qu LY; Wen H; Zhong HS; Xu K; Qiu XS; Wang EH
Int J Clin Exp Pathol; 2014; 7(10):7304-11. PubMed ID: 25400829
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.
Lin CI; Du J; Shen WT; Whang EE; Donner DB; Griff N; He F; Moore FD; Clark OH; Ruan DT
J Clin Endocrinol Metab; 2011 Mar; 96(3):E554-65. PubMed ID: 21190978
[TBL] [Abstract][Full Text] [Related]
10. Mig-6 controls EGFR trafficking and suppresses gliomagenesis.
Ying H; Zheng H; Scott K; Wiedemeyer R; Yan H; Lim C; Huang J; Dhakal S; Ivanova E; Xiao Y; Zhang H; Hu J; Stommel JM; Lee MA; Chen AJ; Paik JH; Segatto O; Brennan C; Elferink LA; Wang YA; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6912-7. PubMed ID: 20351267
[TBL] [Abstract][Full Text] [Related]
11. Generation of a Mig-6 conditional null allele.
Jin N; Gilbert JL; Broaddus RR; Demayo FJ; Jeong JW
Genesis; 2007 Nov; 45(11):716-21. PubMed ID: 17987665
[TBL] [Abstract][Full Text] [Related]
12. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.
Jeong JW; Lee HS; Lee KY; White LD; Broaddus RR; Zhang YW; Vande Woude GF; Giudice LC; Young SL; Lessey BA; Tsai SY; Lydon JP; DeMayo FJ
Proc Natl Acad Sci U S A; 2009 May; 106(21):8677-82. PubMed ID: 19439667
[TBL] [Abstract][Full Text] [Related]
13. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
[TBL] [Abstract][Full Text] [Related]
14. Mig-6, signal transduction, stress response and cancer.
Zhang YW; Vande Woude GF
Cell Cycle; 2007 Mar; 6(5):507-13. PubMed ID: 17351343
[TBL] [Abstract][Full Text] [Related]
15. MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells.
Yoo JY; Yang WS; Lee JH; Kim BG; Broaddus RR; Lim JM; Kim TH; Jeong JW
Oncogene; 2018 Jan; 37(2):255-262. PubMed ID: 28925396
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Cdc42 is essential for Mig-6 suppression of cell migration induced by EGF.
Jiang X; Niu M; Chen D; Chen J; Cao Y; Li X; Ying H; Bergholz J; Zhang Y; Xiao ZX
Oncotarget; 2016 Aug; 7(31):49180-49193. PubMed ID: 27341132
[TBL] [Abstract][Full Text] [Related]
17. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function.
Xu D; Makkinje A; Kyriakis JM
J Biol Chem; 2005 Jan; 280(4):2924-33. PubMed ID: 15556944
[TBL] [Abstract][Full Text] [Related]
18. Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity.
Lin CI; Barletta JA; Nehs MA; Morris ZS; Donner DB; Whang EE; Jeong JW; Kimura S; Moore FD; Ruan DT
Surgery; 2011 Dec; 150(6):1295-302. PubMed ID: 22136853
[TBL] [Abstract][Full Text] [Related]
19. Role of Mig-6 in hepatic glucose metabolism.
Yoo JY; Kim TH; Kong S; Lee JH; Choi W; Kim KS; Kim HJ; Jeong JW; Ku BJ
J Diabetes; 2016 Jan; 8(1):86-97. PubMed ID: 25594850
[TBL] [Abstract][Full Text] [Related]
20. Mig-6 Mouse Model of Endometrial Cancer.
Kim TH; Yoo JY; Jeong JW
Adv Exp Med Biol; 2017; 943():243-259. PubMed ID: 27910070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]